CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 113,243	$ 63,731
General and administrative	36,249	22,377
Total operating expenses	149,492	86,108
Loss from operations	(149,492)	(86,108)
Other income (expense):
Interest income and other income (expense), net	23,273	4,254
Total other income (expense), net	23,273	4,254
Net loss	$ (126,219)	$ (81,854)
Net loss per share attributable to common stockholders, basic	$ (2.17)	$ (1.65)
Net loss per share attributable to common stockholders, diluted	$ (2.17)	$ (1.65)
Weighted average shares of common stock outstanding, basic	58,223,339	49,668,864
Weighted average shares of common stock outstanding, diluted	58,223,339	49,668,864
Comprehensive loss:
Net loss	$ (126,219)	$ (81,854)
Other comprehensive income (loss):
Unrealized gains (losses) on marketable securities	525	(266)
Comprehensive loss	$ (125,694)	$ (82,120)